Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Grazoprevir, a second generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets, has good activity against a range of hepatitis C virus genotype variants, including some that are resistant to most currently used antiviral medications.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | Inquiry | |
50 mg | 6-8 weeks | Inquiry | |
100 mg | 6-8 weeks | Inquiry |
Description | Grazoprevir, a second generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets, has good activity against a range of hepatitis C virus genotype variants, including some that are resistant to most currently used antiviral medications. |
Targets&IC50 | GT1a:0.01±0.01 nM (Ki), GT1b:0.01±<0.01 nM (Ki), GT2a:0.08±0.02 nM (Ki), GT2b:0.15±0.06 nM (Ki), GT3a:0.90±0.2 nM (Ki) |
Synonyms | Grazoprevir, MK5172, MK 5172, MK-5172 |
Molecular Weight | 784.92 |
Formula | C38H52N6O10S |
CAS No. | 1350462-55-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Soluble
H2O: Insoluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Grazoprevir hydrate 1350462-55-3 Grazoprevir Hydrate Grazoprevir MK5172 MK 5172 MK-5172 inhibitor inhibit